ApicHope Pharmaceutical Co (SZSE:300723) 3-Year EBITDA Growth Rate : 12.00% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is ApicHope Pharmaceutical Co 3-Year EBITDA Growth Rate?

ApicHope Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.27.

During the past 12 months, ApicHope Pharmaceutical Co's average EBITDA Per Share Growth Rate was -33.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of ApicHope Pharmaceutical Co was 24.30% per year. The lowest was -6.40% per year. And the median was 13.90% per year.

Competitive Comparison of ApicHope Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, ApicHope Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ApicHope Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ApicHope Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ApicHope Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

ApicHope Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

ApicHope Pharmaceutical Co (SZSE:300723) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

ApicHope Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ApicHope Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

ApicHope Pharmaceutical Co (SZSE:300723) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ApicHope Pharmaceutical Co Ltd (SZSE:300723) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Tianhe District Zhujiang New City Jinsui Road, 17th Floor, Star International Building, Guangdong Province, Guangzhou, CHN, 510623

Website

http://www.gdyph.com

ApicHope Pharmaceutical Co Ltd is a fully integrated, research-oriented pharmaceutical and healthcare company. It is engaged in the research and development, production, and sale of pharmaceutical products. The company focuses on pediatric diseases, recombinant vaccines and chronic diseases.

Executives

Yang De Ming	Independent director
Zhang Ming Yuan	Secretary Dong
Zhang Ying Ying	Supervisors
Li Han Dong	Director
Ke Rui Yu	Supervisors
Zhang Hui Xing	Executives

ApicHope Pharmaceutical Co (SZSE:300723) Headlines

No Headlines